Avita
-
Avita Medical to Distribute “Spray-On Skin†in Taiwan
Avita Medical has secured regulatory approval for its ReCell autologous spray-on skin from the Taiwan Ministry of Health. The target market for the product includes plastic and reconstructive surgeons, dermatologists, burns specialists and cosmeti…
Avita | 22 April 2010
-
Avita Medical Receives Grant from US Armed Forces
Avita Medical has been awarded an additional US$450 thousand from the US Armed Forces Institute of Regenerative Medicine (AFIRM) to expedite approval of the company’s ReCell Autologous Spray On Skin in the US market. The award is in addition to the…
Avita | 04 February 2010
-
ReCell Receives FDA Approval for Clinical Trial
Avita Medical has received approval from the US Food and Drug Administration (FDA) to begin its US clinical trial for ReCell Spray-On Skin, a stand-alone regenerative point-of-care device enabling surgeons to treat burns, wounds and chronic skin defe…
Avita | 25 December 2009
